Archives of Dermatological Research

, Volume 288, Issue 12, pp 757–764 | Cite as

Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9) in psoriatic dermis

  • Noel Djemadji-Oudjiel
  • Sergij Goerdt
  • Vitam Kodelja
  • Matthias Schmuth
  • Constantin E. Orfanos
Original Paper


Immunological mechanisms play an important role in the pathogenesis of psoriasis. Lesional psoriatic skin-derived T-cell clones have been shown to stimulate keratinocyte proliferation and to predominantly express a T-helper type 1 cytokine pattern. However, T-helper type 2-like cytokines have also been identified in some psoriatic T-cell clones. In parallel to the T-helper type 1/type 2 dichotomy, a distinction between interferon-γ-induced (classically activated) macrophages and interleukin-4/glucocorticoid-induced (alternatively activated) macrophages has been put forward as a conceptual framework for a better understanding of immunopathological processes. In the present study, the phenotype of mononuclear phagocytes in psoriatic skin lesions (n=21), allergic contact dermatitis (n=4) and normal skin (n=2) was investigated using a panel of monoclonal antibodies (mAb) against monocytes/macrophages and dendritic cells (mAb MS-1, RM 3/1 and 25F9 against subsets of in vitro alternatively activated macrophages, and mAb against myeloid antigens CD1a, CD11b, CD11c, CD34, CD36, and CD68). With regard to mononuclear phagocytes, psoriatic skin was found to be compart-mentalized into epidermis, subepidermal space, and upper and lower dermis. RM 3/1+++, MS-1± 25F9 dendritic macrophages previously classified as type II alternatively activated macrophages were the dominant dermal macrophage population in psoriatic skin, while intraepidermal and epithelium-lining macrophages expressed a different, presumably classically activated, macrophage phenotype (RM 3/1, MS-1, 25F9, CD68++, CD11b++). In allergic contact dermatitis a classical T-helper type 1 disease, RM 3/1+++ macrophages were less prominent. Since MS-1 high molecular weight protein is much more sensitive to interferon-γ-induced suppression than RM 3/1 antigen a predominance of T-helper type 1 cytokines in psoriasis could explain why dermal dendritic macrophages do not express the fully induced MS-1+++, RM 3/1+++, 25F9± phenotype of type I alternatively activated macrophages.

Key words

Psoriasis Mononuclear phagocytes Alternatively activated macrophages MS-1 high molecular weight protein RM 3/1 antigen 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baker BS, Bokth S, Powles A, Garioch JJ, Lewis H, Valdimarsson H, Fry L (1993) Group A streptococcal antigen-specific T-lymphocytes in guttate psoriatic lesions. Br J Dermatol 128: 493–499PubMedCrossRefGoogle Scholar
  2. 2.
    Barna M, Snijdewint FGM, Heijden FL, van der Bos JD, Kapsenberg ML (1994) Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venerol Suppl (Stockh) 186:9–11Google Scholar
  3. 3.
    Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154: 1280–1286PubMedGoogle Scholar
  4. 4.
    Boehncke WH, Küenzlen C, Zollner TM, Mielke V, Sterry W (1994) Predominant usage of distinct T-cell receptor Vβ regions by epidermotropic T cells in psoriasis. Exp Dermatol 3: 161–163PubMedCrossRefGoogle Scholar
  5. 5.
    Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258–261PubMedCrossRefGoogle Scholar
  6. 6.
    Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu Y-J, Banchereau J (1994) Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 6:1177–1185PubMedGoogle Scholar
  7. 7.
    Cowan HB, Vick S, Conary JT, Shepherd VL (1992) Dexamethasone upregulates mannose receptor activity by increasing mRNA levels. Arch Biochem Biophys 296:314–320PubMedCrossRefGoogle Scholar
  8. 8.
    Dunham DM, Arkins S, Edwards CK, Dantzer R, Kelley KW (1990) Role of interferon-γ in counteracting the suppressive effects of transforming growth factor-β2 and glucocorticoids on the production of tumor necrosis factor-α. J Leukoc Biol 48: 473–481.PubMedGoogle Scholar
  9. 9.
    Elder IT, Nair RP, Guo S-W, Henseler T, Christophers E (1994) The genetics of psoriasis. Arch Dermatol 130: 216–224PubMedCrossRefGoogle Scholar
  10. 10.
    Enk AH, Angeloni VL, Udey MC, Katz SI (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151: 2390–2398PubMedGoogle Scholar
  11. 11.
    Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann AA, Stingl G, Berger R (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127–131PubMedCrossRefGoogle Scholar
  12. 12.
    Goerdt S, Steckel F, Schulze-Osthoff K, Hagemeier H-H, Macher E, Sorg C (1989) Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelia, in skin vascular lesions and in vitro. Exp Cell Biol 57: 185–192PubMedGoogle Scholar
  13. 13.
    Goerdt S, Walsh LJ, Murphy GF, Pober JS (1991) Identification of a novel high molecular weight protein antigen preferentially expressed by sinusoidal endothelial cells innormal human tissues. J Cell Biol 113: 1425–1437PubMedCrossRefGoogle Scholar
  14. 14.
    Goerdt S, Bhardwaj R, Sorg C (1993) Inducible expression of MS-1 high molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 142: 1409–1422PubMedGoogle Scholar
  15. 15.
    Griffiths CEM (1994) Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 130: 494–499PubMedCrossRefGoogle Scholar
  16. 16.
    Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ (1993) Synovial fluid macrophages and blood monocytes differ in their response to IL-4. J Immunol 151: 3370–3380PubMedGoogle Scholar
  17. 17.
    Heng MCY, Kloss SG, Kuehn CS, Chase DG (1986) Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol 87: 362–366PubMedCrossRefGoogle Scholar
  18. 18.
    Heng MCY, Allen SG, Haberfelde G, Song MK (1991) Electron microscopic and immunocytochemical studies of the sequence of events in psoriatic plaque formation following tape stripping. Br J Dermatol 125: 548–556PubMedCrossRefGoogle Scholar
  19. 19.
    Kodelja V, Goerdt S (1994) Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro. Exp Dermatol 3: 257–268PubMedCrossRefGoogle Scholar
  20. 20.
    Kristensen M, Deleuran B, Eedy DJ, Feldman M, Breathnach SM, Brennan FM (1992) Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1α in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis. Br J Dermatol 127: 305–311PubMedCrossRefGoogle Scholar
  21. 21.
    Lewis HM, Baker BS, Bokth S, Powles AV, Garioch JJ, Valdimarsson H, Fry L (1993) Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 129: 514–520PubMedCrossRefGoogle Scholar
  22. 22.
    Liew FY, Li Y, Severn A, Millott S, Schmidt J, Salter M, Moncada S (1991) A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 21: 2489–2494PubMedGoogle Scholar
  23. 23.
    Manetti R, Parronchi P, Giudizi MG, Piccini MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199–1204PubMedCrossRefGoogle Scholar
  24. 24.
    Marianayagam L, Poulter LW (1991) Corticosteroid can alter antigen expression on alveolar macrophages. Clin Exp Immunol 85: 531–535PubMedCrossRefGoogle Scholar
  25. 25.
    McKenzie ANJ, Culpepper JA, Waal Malefyt R de, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, Vries JE de, Banchereau J, Zurawski G (1993) Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 90: 3735–3739PubMedCrossRefGoogle Scholar
  26. 26.
    Minty A, Chalon P, Derocq JM, Dumont X, Guilemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248–250PubMedCrossRefGoogle Scholar
  27. 27.
    Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrara P, Gordon S (1993) Interleukin-13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med 178: 743–747PubMedCrossRefGoogle Scholar
  28. 28.
    Nestle FO, Turka LA, Nickoloff BJ (1994) Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphcytes and induction of TH1 type cytokines. J Clin Invest 94: 202–209PubMedCrossRefGoogle Scholar
  29. 29.
    Oord van den JJ, Wolf-Peeters C de (1994) Epithelium-lining macrophages in psoriasis. Br J Dermatol 130: 589–594PubMedCrossRefGoogle Scholar
  30. 30.
    Paukkonen K, Naukkarinen A, Horsmanheimo M (1992) The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 284: 375–379PubMedCrossRefGoogle Scholar
  31. 31.
    Pigatto PD, Pigatto LB, Bigardi A, Altomare G, Finzi AF (1990) Factors secreted by untreated psoriatic monocytes enhance neutrophil function. J Invest Dermatol 94: 372–376PubMedCrossRefGoogle Scholar
  32. 32.
    Prens EP, Benne K, Joost T van, Benner R (1991) The autologous mixed epidermal cell T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a-antigen-presenting cells. J Invest Dermatol 96: 880–887PubMedCrossRefGoogle Scholar
  33. 33.
    Prinz JC, Gross B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G (1994) T cell clones from psoriasis skin lesions can promote kereatinocyte proliferation in vitro via secreted products. Eur J Immunol 24: 593–598PubMedGoogle Scholar
  34. 34.
    Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, Waal Malefyt R de, Vries JE de (1993) Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90: 3730–3734PubMedCrossRefGoogle Scholar
  35. 35.
    Rein G, Abraham A, Raychadauri SP, Weltman H (1994) Monocyte adhesion to fibronectin in psoriasis. Int J Dermatol 33: 374–379PubMedGoogle Scholar
  36. 36.
    Rieger-Wettengl G, Castellucci M, Schulze H-J (1994) Subepidermal macrophages—a diagnostic marker for psoriasis versus psoriasiform dermatitis (abstract). Arch Dermatol Res 286: 207Google Scholar
  37. 37.
    Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389–400PubMedCrossRefGoogle Scholar
  38. 38.
    Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE (1992) TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52: 274–281PubMedGoogle Scholar
  39. 39.
    Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde K-H, Fleischer B (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102: 145–149PubMedCrossRefGoogle Scholar
  40. 40.
    Schmitt-Egenolf M, Boehncke W-H, Ständer M, Eiermann TH, Sterry W (1993) Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, −DQ1*0201, −DQB1*0303 extended haplotype. J Invest Dermatol 100: 749–752PubMedCrossRefGoogle Scholar
  41. 41.
    Schopf RE, Dobmeyer J, Dobmeyer T, Morsches B (1993) Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis. Dermatology 186: 45–49PubMedCrossRefGoogle Scholar
  42. 42.
    Schubert C, Christophers E (1985) Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 277: 352–358PubMedCrossRefGoogle Scholar
  43. 43.
    Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260: 496–497PubMedCrossRefGoogle Scholar
  44. 44.
    Spiteri MA, Poulter LW (1991) Characterization of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 83: 157–162PubMedCrossRefGoogle Scholar
  45. 45.
    Spiteri MA, Clarke SW, Poulter LW (1988) Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 74: 359–364PubMedGoogle Scholar
  46. 46.
    Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287–292PubMedCrossRefGoogle Scholar
  47. 47.
    Sterry W, Boehnke W-H (1993) Phenotypic heterogeneity of the dermal monocyte/macrophage system. In: Nickoloff BJ (ed) Dermal immune system. CRC Press, Boca Raton, pp 67–89Google Scholar
  48. 48.
    Stingl G, Bergstresser PR (1995) Dendritic cells: a major story unfolds. Immunol Today 16: 330–333PubMedCrossRefGoogle Scholar
  49. 49.
    Strange P, Cooper KD, Hansen ER, Fisher G, Larsen JK, Fox D, Krag C, Voorhees JJ, Baadsgaard O (1993) T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinoyte proliferation. J Invest Dermatol 101: 695–700PubMedCrossRefGoogle Scholar
  50. 50.
    Tanaka M, Lee K, Yodoi J, Saito H, Iwai Y, Kim K-M, Morita M, Mayumi M, Mikawa H (1989) Regulation of FcεRII (CD23) expression on a human eosinophilic cell line EoL3 and a human monocytic cell line U937. Cell Immunol 122: 96–107PubMedCrossRefGoogle Scholar
  51. 51.
    Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, Bowcock A (1994) Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264: 1141–1145PubMedCrossRefGoogle Scholar
  52. 52.
    Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101: 701–705PubMedCrossRefGoogle Scholar
  53. 53.
    Villanueva POF, Harris TS, Ricklan DE, Stadecker MJ (1994) Macrophages from schistosomal egg granulomas induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J Immunol 152: 1847–1855Google Scholar
  54. 54.
    Villanueva POF, Reiser H, Stadecker MJ (1994) Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. J Immunol 153: 5190–5199Google Scholar
  55. 55.
    Vollmor S, Menssen A, Trommler P, Schendel D, Prinz JC (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 2377–2382Google Scholar
  56. 56.
    Waal Malefyt R de, Haanen J, Spits H, Roncarolo M-G, Velde A te, Figdor C, Johnson K, Kastelein R, Yssel H, Vries JE de (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915–924PubMedCrossRefGoogle Scholar
  57. 57.
    Walsh LJ, Goerdt S, Pober JS, Sueki H, Murphy GF (1991) MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab Invest 65: 732–741PubMedGoogle Scholar
  58. 58.
    Weber-Matthiesen K, Sterry W (1990) Organisation of the monocyte/macrophage system of normal human skin. J Invest Dermatol 95: 83–89PubMedCrossRefGoogle Scholar
  59. 59.
    Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ (1988) Transforming growth factor-β is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793–800PubMedCrossRefGoogle Scholar
  60. 60.
    Wölfer L-U, Djemadji-Oudjiel N, Hiletework M, Tebbe B, Husak R, Goerdt S, Orfanos CE (1996) HIV-assoziierte Psoriasis. Klinische und histologische Beobachtungen an 36 Patientten. Hautzartz (in press)Google Scholar
  61. 61.
    Wölfer L-U, Goerdt S, Schröder K, Zouboulis CC, Orfanos E (1996) Interferon-γ-induzierte Psoriasis. Hautarzt 47: 124–128PubMedCrossRefGoogle Scholar
  62. 62.
    Zlotnik A, Moore KW (1992) Interleukin 10. Cytokine 3: 366–371CrossRefGoogle Scholar
  63. 63.
    Zurawski SM, Vega F Jr, Huyghe B, Zurawski G (1993) Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663–2670PubMedGoogle Scholar
  64. 64.
    Zwadlo G, Bröcker EB, Bassewitz D-B von, Feige U, Sorg C (1985) A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134: 1487–1492PubMedGoogle Scholar
  65. 65.
    Zwadlo G, Voegeli R, Schulze-Osthoff K, Sorg C (1987) A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55: 295–304PubMedCrossRefGoogle Scholar
  66. 66.
    Zwadlo-Klarwasser G, Bent S, Haubeck H-D, Sorg C, Schmutzler W (1990) Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood in man. Int Arch Allergy Appl Immunol 91: 175–180PubMedGoogle Scholar
  67. 67.
    Zwadlo-Klarwasser G, Bent S, Schmutzler W (1991) Comparison of dermal and systemic application of glucocorticoids on the RM 3/1+ macrophages in human blood. Int Arch Allergy Appl Immunol 94: 278–279PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Noel Djemadji-Oudjiel
    • 1
    • 2
  • Sergij Goerdt
    • 2
  • Vitam Kodelja
    • 2
  • Matthias Schmuth
    • 2
  • Constantin E. Orfanos
    • 2
  1. 1.Hôpital Central de N’DjamenaN’Djamena, Tschad
  2. 2.Hautklinik und Poliklinik Universitätsklinikum Benjamin FranklinFreic Universität BerlinBerlinGermany

Personalised recommendations